Conmed earnings were $47.1M for the trailing 12 months ending Dec 31, 2025, with -64.6% growth year over year. The latest CNMD earnings report on Dec 31, 2025 announced Q4 2025 earnings of $16.7M, up 485.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CNMD reported annual earnings of $47.1M, with -64.5% growth.
CNMD past earnings growth
How has CNMD's earnings growth performed historically?
On CNMD's earnings call on Invalid Date, Conmed (NYSE: CNMD) reported Q4 2025 earnings per share (EPS) of $0.54, up 50.46% year over year. Total CNMD earnings for the quarter were $16.74 million. In the same quarter last year, Conmed's earnings per share (EPS) was $1.09.
As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $47.06 million, a 64.47% decrease year over year.
What was CNMD's earnings growth in the past year?
As of Conmed's earnings date in Invalid Date, Conmed's earnings has grown -64.57% year over year. This is 88.2 percentage points lower than the US Medical Devices industry earnings growth rate of 23.63%. CNMD earnings in the past year totalled $47.06 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.